Tower Research Capital LLC (Trc) Eton Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$3.06 - $3.75 $12,102 - $14,831	-3,955 Reduced 52.09%	3,638 $11,000
Q1 2024 May 15, 2024	BUY	$3.48 - $5.03 $12,287 - $17,760	3,531 Added 86.93%	7,593 $28,000
Q4 2023 Feb 13, 2024	BUY	$3.45 - $4.66 $9,970 - $13,467	2,890 Added 246.59%	4,062 $17,000
Q3 2023 Nov 14, 2023	SELL	$2.55 - $5.63 $8,165 - $18,027	-3,202 Reduced 73.21%	1,172 $4,000
Q2 2023 Aug 14, 2023	BUY	$3.32 - $4.04 $3,230 - $3,930	973 Added 28.61%	4,374 $15,000
Q1 2023 May 09, 2023	SELL	$2.89 - $4.1 $710 - $1,008	-246 Reduced 6.75%	3,401 $13,000
Q4 2022 Feb 10, 2023	SELL	$2.02 - $3.25 $4,147 - $6,672	-2,053 Reduced 36.02%	3,647 $10,000
Q3 2022 Nov 10, 2022	BUY	$2.04 - $3.03 $7,413 - $11,011	3,634 Added 175.9%	5,700 $12,000
Q2 2022 Aug 15, 2022	BUY	$2.55 - $4.38 $1,856 - $3,188	728 Added 54.41%	2,066 $5,000
Q1 2022 May 12, 2022	BUY	$3.43 - $4.69 $4,589 - $6,275	1,338 New	1,338 $6,000
Q4 2021 Feb 14, 2022	SELL	$3.66 - $6.59 $16,038 - $28,877	-4,382 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.2 - $6.26 $18,404 - $27,431	4,382 New	4,382 $22,000
Q2 2021 Aug 16, 2021	SELL	$5.71 - $8.85 $15,782 - $24,461	-2,764 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.93 - $10.07 $3,160 - $4,591	456 Added 19.76%	2,764 $20,000
Q4 2020 Feb 16, 2021	SELL	$6.65 - $8.83 $77,326 - $102,675	-11,628 Reduced 83.44%	2,308 $19,000
Q3 2020 Nov 16, 2020	SELL	$4.96 - $9.06 $9,672 - $17,667	-1,950 Reduced 12.27%	13,936 $110,000
Q2 2020 Aug 13, 2020	BUY	$3.5 - $6.09 $55,601 - $96,745	15,886 New	15,886 $87,000
Q1 2020 May 15, 2020	SELL	$2.87 - $7.47 $63 - $164	-22 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$5.59 - $7.2 $7,183 - $9,252	-1,285 Reduced 98.32%	22 $0
Q3 2019 Nov 05, 2019	SELL	$5.19 - $8.72 $9,508 - $15,975	-1,832 Reduced 58.36%	1,307 $8,000
Q2 2019 Aug 13, 2019	BUY	$7.1 - $8.39 $12,268 - $14,497	1,728 Added 122.47%	3,139 $25,000
Q1 2019 May 14, 2019	BUY	$5.72 - $8.0 $7,161 - $10,016	1,252 Added 787.42%	1,411 $11,000
Q4 2018 Feb 14, 2019	BUY	$5.79 - $6.68 $920 - $1,062	159 New	159 $1,000

Others Institutions Holding ETON

# of Institutions

Shares Held

9.44M

Call Options Held

261K

Put Options Held

500

Opaleye Management Inc. Boston, MA

2.78M
Shares

$36.3 Million
3.05% of portfolio
Vanguard Group Inc Valley Forge, PA

1.03M
Shares

$13.4 Million
0.0% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

999K
Shares

$13 Million
0.36% of portfolio
Westside Investment Management, Inc.

619K
Shares

$8.07 Million
0.79% of portfolio
Acuitas Investments, LLC

580K
Shares

$7.57 Million
1.66% of portfolio

View Full List

About Eton Pharmaceuticals, Inc.

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $330M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

More about ETON

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account